100 Million Refugee Mothers

Empowering pregnant women with life saving nutrition

“The return on investment in nutrition is unparalleled. For every dollar spent, we gain $16 in improved health, education, and economic outcomes.”

– World Bank

100 Million Refugee Mothers is MNF’s flagship intervention, designed to scale access to Multiple Micronutrient Supplements (MMS) for 100 million pregnant women over the next 20 years. Each pregnancy receives a full course of 180 tablets, totaling 18 billion MMS tablets, one of the largest maternal nutrition efforts ever undertaken.

By addressing the most urgent nutritional gaps during pregnancy, this initiative reduces maternal anaemia, prevents low birthweight and preterm births, and lowers neonatal mortality, while supporting healthier early development for children.

Program Targets

Metric
Annual
20-Year Total
MMS tablets distributed
Pregnant women reached
Maternal anaemia cases prevented
Neonatal deaths averted

The program has soft launched, with 70 million Multiple Micronutrient Supplement (MMS) tablets already distributed to 388,800 pregnant women across 54 refugee and internally displaced persons (IDP) camps in:

What We Have Achieved So Far

The program has soft launched, with 70 million Multiple Micronutrient Supplement (MMS) tablets already distributed to 388,800 pregnant women across 54 refugee and internally displaced persons (IDP) camps in:

Nigeria, Cameroon, Chad, Central African Republic, Niger, Sudan, South Sudan, and the Democratic Republic of Congo.

This marks the first phase of the 100 Million Refugee Mothers initiative, demonstrating MNF’s ability to deliver at scale in fragile, high-need settings while strengthening supply chains, accelerating national readiness, and validating the multi-country delivery framework ahead of full global rollout.

Why MMS?

Multiple Micronutrient Supplements (MMS) contain 15 essential nutrients tailored to the needs of pregnancy. Backed by over 20 years of clinical evidence and endorsed by World Health Organization (WHO) and UNICEF, MMS has been proven more effective than traditional iron-folic acid (IFA) supplements in improving maternal and newborn outcomes.

Key Benefits of MMS Compared to IFA:

  • 12–19% reduction in low birthweight
  • 6–16% reduction in preterm births
  • 8–11% reduction in stillbirths
  • Up to 29% reduction in infant mortality in anaemic mothers
  • Over 5 million additional school years gained through improved early childhood development

Systems-Level Change

100 Million Refugee Mothers is more than a supplement program, it’s a platform for resilient, country-led maternal health transformation.

MNF drives systems change by:

  • Supporting local MMS manufacturing, reducing costs by up to 50%
  • Strengthening supply chains and digital monitoring systems
  • Integrating maternal nutrition into national health strategies and antenatal care guidelines
  • Generating local employment in the health, logistics, and pharmaceutical sectors

Priority Countries

The 100 Million Refugee Mothers program launches in 8 priority crisis-affected countries, scaling rapidly to 21, and ultimately to 63 countries, ensuring global reach:

Become a Donor

Let's Make a Difference